MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER
|
Back to Search Results |
|
Model Number PED2-500-20 |
Device Problem
Activation Failure (3270)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/26/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received a report that at the time of releasing the pipeline, it did not open properly at the distal end despite multiple maneuvers and waiting a prudent time for the opening to be optimal.It was noted the middle section was positioning in a bend, resheathing was performed less than 3 times, and no additional devices/steps were taken in an attempt to open the stent.There had been no friction during delivery and no catheter jump.Three-fourths of the device was released, and finally the neurointerventionist decided to remove the pipeline to avoid any thrombotic and/or ischemic complications.When analyzing it on the work table, it was totally released and it was identified both ends did not have an adequate opening despite being totally detached.Another pipeline was implanted and adequate appositioning was achieved and patency of the entire vascular system.It was indicated that all devices were prepared as per the instructions for use (ifu), and no patient symptoms or further complications were reported as a result of this event.The patient was undergoing surgery for treatment of a saccular, unruptured aneurysm of the left superior pituitary with a max diameter of 5 mm and a 5 mm neck diameter.It was noted the patient's vessel tortuosity was minimal.
|
|
Event Description
|
No additional information received.
|
|
Manufacturer Narrative
|
H3: analysis of the pipeline flex shield braid (lot no.A688048) found that the distal and proximal ends appeared to be opened and moderately frayed.No other anomalies were observed.Based on the returned device, the pipeline flex shield was not confirmed to have failure to open at the distal and proximal ends.The root cause could not be determined as the distal and proximal ends of pipeline flex shield braid were opened and moderately frayed.The damage to the braid on the ends of the pipeline flex shield braid is likely the results of the physician re-sheathing the device more than recommended two times.Possible cause of failure to open includes vessel tortuosity.There was no non-conformance to specifications identified that led to the failure to open issue.Per our instructions for use (ifu): ¿begin to deliver the device using a combination of unsheathing the pipeline flex shield embolization device and pushing delivery wire simultaneously.After the distal end of the pipeline flex shield embolization device has successfully expanded, deploy the remainder of pipeline flex shield embolization device by pushing the delivery wire and/or unsheathing the pipeline flex shield embolization device.Resheathing and/or manipulation of the micro catheter, by locking down the delivery wire and moving both as a system, may facilitate expansion of the pipeline flex shield embolization device.The system is designed to allow for 2 full cycles of re-sheathing of the pipeline flex shield embolization device.Re-sheathing the pipeline flex shield embolization device more than 2 full cycles may cause damage to the distal or proximal ends of the braid.Do not use in patients in whom the angiography demonstrates the anatomy is not appropriate for endovascular treatment, due to conditions such as severe intracranial vessel tortuosity or stenosis.¿ h6: method code updated to b19.Result code updated to c070601.Conclusion code updated to d15.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|